Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
US8039010B2 · kind B2 · utility
13Cited by
19References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2006 |
| Grant date | Oct 18, 2011 |
| Priority date | — |
| Expiry date | Nov 3, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A biocompatible, sustained release intraocular drug delivery system comprising a protein or polynucleotide therapeutic agent, a polymeric carrier for the therapeutic agent and a long chain fatty alcohol release modifier. The biocompatible, sustained release intraocular drug delivery system can be used to treat an ocular condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.